Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes

Affiliations

¹ Department of Urology and Pediatric Urology, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131, Mainz, Germany. igor.tsaur@unimedizin-mainz.de.
² Department of Urology and Pediatric Urology, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131, Mainz, Germany.
³ Department of Urology, CHU-Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.
⁴ Department of Urology, La Croix du Sud Hospital, Toulouse, France.

Published Erratum

Igor Tsaur et al. World J Urol. 2022 Apr.

. 2022 Apr;40(4):1089.

doi: 10.1007/s00345-021-03849-5.

¹ Department of Urology and Pediatric Urology, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131, Mainz, Germany. igor.tsaur@unimedizin-mainz.de.
² Department of Urology and Pediatric Urology, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131, Mainz, Germany.
³ Department of Urology, CHU-Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.
⁴ Department of Urology, La Croix du Sud Hospital, Toulouse, France.

No abstract available

Erratum for

Immunotherapy in prostate cancer: new horizon of hurdles and hopes.
Tsaur I, Brandt MP, Juengel E, Manceau C, Ploussard G. Tsaur I, et al. World J Urol. 2021 May;39(5):1387-1403. doi: 10.1007/s00345-020-03497-1. Epub 2020 Oct 26. World J Urol. 2021. PMID: 33106940 Free PMC article. Review.